Winrevair Side Effects

Generic name: sotatercept

Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.

Note: This document provides detailed information about Winrevair.

Applies to sotatercept: parenteral powder for injection Side Effects associated with sotatercept. Some dosage forms listed on this page may not apply specifically to the brand name Winrevair.

Applies to sotatercept: parenteral powder for injection.

Side effects include:

Most common adverse effects (≥10%): headache, epistaxis, rash, telangiectasia, diarrhea, dizziness, erythema.

For healthcare professionals

Applies to sotatercept: subcutaneous kit.

General adverse events

The most common adverse reactions occurring in 10% of patients or greater included increased hemoglobin, decreased platelets, headache, epistaxis, rash, telangiectasia, diarrhea, dizziness, and erythema.^[Ref]

Cardiovascular

• Frequency not reported: Increased blood pressure

Dermatologic

• Very common (10% or more): Rash (20.2%), telangiectasia (16.6%), erythema (13.5%)

Gastrointestinal

• Very common (10% or more): Diarrhea (15.3%)

Hematologic

• Very common (10% or more): Increased hemoglobin (53%), decreased platelets (25%)
• Common (1% to 10%): Serious bleeding (e.g., gastrointestinal, intracranial hemorrhage), severe thrombocytopenia (platelet count less than 50,000/mm3)

Immunologic

• Very common (10% or more): Antidrug antibodies (27%)
• Common (1% to 10%): Neutralizing antibodies positive

Nervous system

• Very common (10% or more): Headache (24.5%), dizziness (14.7%)

Respiratory

• Very common (10% or more): Epistaxis (22.1%)

Further information

Winrevair side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer